Dr. Matthew D Hellmann MD
Hematologist-Oncologist | Hematology & Oncology
Massachusetts General Hospital 55 Fruit Street Boston MA, 02114About
I am a medical oncologist who specializes in the care of patients with lung cancers, particularly non small-cell lung cancers. I am dedicated to identifying better treatments for people with all stage ...
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Nivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer.
- Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.
- ORAL01.03: CheckMate 012: Safety and Efficacy of First-Line Nivolumab and Ipilimumab in Advanced NSCLC: Topic: Medical Oncology.
- Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer.
- 'Genotype/immunotype' correlations in resected NSCLC.
- Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab.
- Reply to M. Nishino et al.
- Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas.
- Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors.
- Making It Personal: Neoantigen Vaccines in Metastatic Melanoma.
- Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).
- Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.
Clinical Trials
- Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.
- A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer
- Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
- Evaluate the Mediators of Sensitivity and Resistance to Nivolumab Plus Ipilimumab in Patients With Advanced NSCLCs
Treatments
- Lung Cancer, Immunotherapy, Clinical Trials
Dr. Matthew D Hellmann MD's Practice location
Dr. Matthew D Hellmann MD's reviews
Write ReviewPatient Experience with Dr. Hellmann
Recommended Articles
- This New Zealand Native Beat Cancer Eight Times
Being diagnosed with cancer can be a world-shaking experience. Going through the necessary chemotherapy and radiation treatment to beat cancer can be a difficult struggle, but coming out cancer-free feels incredibly liberating.Maybe it’s that feeling of having beaten cancer that can make suffering...
- Teen with Hodgkin Lymphoma Skates with Her Hero, Mario Lemieux
Lillian Tarasiewicz was diagnosed with stage 3B Hodgkin lymphoma in October of 2015. She currently resides in South Carolina, but because of her father’s Pennsylvania background, she grew up with a love for hockey and for the Pittsburgh Penguins. She always felt a special connection to Mario...
- Survey Shows Lack of Blood Cancer Knowledge Among Americans
If anyone is asked to describe what cancer is, chances are they’ll be able to provide at least a rough definition of the disease. Generally speaking, cancer is the name for the rapid and uncontrollable development of cells in a certain part of the body. In addition to holding a general awareness...
- The Link Between Lymphoma Radiotherapy and Mesothelioma
One of the more common forms of treatment for lymphoma is radiotherapy. This involves using radiation to kill the cancer cells in the lymph nodes. New studies have produced concerning findings regarding radiation therapy, and point towards another induced risk of using the practice.The StudyThe...
- New Study Discovers How Lymphoma Affects Survivors’ Ability to Work
Young adults in many countries pride themselves on their work. They have worked hard to get to where they are and there is a huge sense of accomplishment in joining the adult world and being able to provide for themselves and their new families if applicable. When cancer comes along, their ability...
- The Leukemia & Lymphoma Society to Expand Mission Against Blood Cancer
On July 19, 2017, the Leukemia & Lymphoma Society, or LLS, proclaimed that they would be expanding their initiative to beat acute myeloid leukemia. Referred to as "Beat AML Master Trial", the project aims to test new and innovative treatments for those suffering from AML. For more information...
Nearby Providers
- Dr. YongLi Ji M.D. , PH.D.55 Fruit St Boston MA 02114
- Dr. Bruno Bastos M.D.44 Binney St Boston MA 02115
- Dr. Gary M. Strauss M.D.18 Acron Road Brookline Massachusetts 2445
- Prabhsimranjot Singh MD17 Faxon St Newton Massachusetts 02458
- Dr. Folefac Edmund M.D.79-81 Highland Ave. Salem MA 01970
- Dr. Susan Tinsley Schumer Other2014 Washington Street Newton Lower Falls MA 02462